Prospect of bacteria for tumor diagnosis and treatment

被引:6
作者
Xu, Yuyao [1 ,2 ]
Zhao, Chenhao [2 ]
Ma, Xin [2 ]
Zhang, Haifang [2 ]
机构
[1] Nanjing Univ Chinese Med, Zhangjiagang Tradit Chinese Med Hosp, Dept Lab Med, Zhangjiagang 215600, Jiangsu, Peoples R China
[2] Soochow Univ, Affiliated Hosp 2, Dept Clin Lab, Suzhou 215000, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Bacterial therapy; Immunology; Biomarkers; Cancer; Tumor; Bacteria; GUT MICROBIOTA; BREAST-CANCER; INTESTINAL MICROBIOTA; PHASE-I; INFLAMMATION; IMMUNITY; THERAPY; EFFICACY; IMMUNOTHERAPY; RESISTANCE;
D O I
10.1016/j.lfs.2022.121215
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In recent decades, the comprehensive cancer treatments including surgery, chemotherapy, and radiotherapy have improved the overall survival rate and quality of life of many cancer patients. However, we are still facing many difficult problems in the cancer treatment, such as unpredictable side effects, high recurrence rate, and poor curative effect. Therefore, the better intervention strategies are needed in this field. In recent years, the role and importance of microbiota in a variety of diseases were focused on as a hot research topic, and the role of some intracellular bacteria of cancer cells in carcinogenesis has recently been discovered. The impact of bacteria on cancer is not limited to their contribution to tumorigenesis, but the overall susceptibility of bacteria to subsequent tumor progression, the development of concurrent infections, and the response to anti-cancer therapy have also been found to be affected. Concerns about the contribution of bacteria in the anti-cancer response have inspired researchers to develop bacteria-based anti-cancer treatments. In this paper, we reviewed the main roles of bacteria in the occurrence and development of tumors, and summarized the mechanism of bacteria in the occurrence, development, and clinical anti-tumor treatment of tumors, providing new insights for the in-depth study of the role of bacteria in tumor diagnosis and treatment. This review aims to provide a new perspective for the development of new technologies based on bacteria to enhance anti-tumor immunotherapy.
引用
收藏
页数:11
相关论文
共 186 条
[1]   Peptides as Potential Anticancer Agents [J].
Aaghaz, Shams ;
Gohel, Vivek ;
Kamal, Ahmed .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (17) :1491-1511
[2]   Ultrasound-controllable engineered bacteria for cancer immunotherapy [J].
Abedi, Mohamad H. ;
Yao, Michael S. ;
Mittelstein, David R. ;
Bar-Zion, Avinoam ;
Swift, Margaret B. ;
Lee-Gosselin, Audrey ;
Barturen-Larrea, Pierina ;
Buss, Marjorie T. ;
Shapiro, Mikhail G. .
NATURE COMMUNICATIONS, 2022, 13 (01)
[3]  
Abedon Stephen T, 2011, Bacteriophage, V1, P66
[4]   Maximizing the recovery of the native p28 bacterial peptide with improved activity and maintained solubility and stability in Escherichia coli BL21 (DE3) [J].
Abuei, Haniyeh ;
Pirouzfar, Mohammad ;
Mojiri, Anahita ;
Behzad-Behbahani, Abbas ;
Kalantari, Tahereh ;
Bemani, Peyman ;
Farhadi, Ali .
JOURNAL OF MICROBIOLOGICAL METHODS, 2022, 200
[5]   The Effect of Bacterial Peptide p28 on Viability and Apoptosis Status of P53-null HeLa Cells [J].
Abuei, Haniyeh ;
Behzad-Behbahani, Abbas ;
Faghihi, Fatemeh ;
Farhadi, Ali ;
Dehbidi, Gholam Reza Rafiei ;
Pirouzfar, Mohammad ;
Zare, Farahnaz .
ADVANCED PHARMACEUTICAL BULLETIN, 2019, 9 (04) :668-673
[6]   Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis [J].
Aceto, Nicola ;
Bardia, Aditya ;
Miyamoto, David T. ;
Donaldson, Maria C. ;
Wittner, Ben S. ;
Spencer, Joel A. ;
Yu, Min ;
Pely, Adam ;
Engstrom, Amanda ;
Zhu, Huili ;
Brannigan, Brian W. ;
Kapur, Ravi ;
Stott, Shannon L. ;
Shioda, Toshi ;
Ramaswamy, Sridhar ;
Ting, David T. ;
Lin, Charles P. ;
Toner, Mehmet ;
Haber, Daniel A. ;
Maheswaran, Shyamala .
CELL, 2014, 158 (05) :1110-1122
[7]   Bacteriolytic therapy can generate a potent immune response against experimental tumors [J].
Agrawal, N ;
Bettegowda, C ;
Cheong, I ;
Geschwind, JF ;
Drake, CG ;
Hipkiss, EL ;
Tatsumi, M ;
Dang, LH ;
Diaz, LA ;
Pomper, M ;
Abusedera, M ;
Wahl, RL ;
Kinzler, KW ;
Zhou, SB ;
Huso, DL ;
Vogelstein, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (42) :15172-15177
[8]   A framework for the development of effective anti-metastatic agents [J].
Anderson, Robin L. ;
Balasas, Theo ;
Callaghan, Juliana ;
Coombes, R. Charles ;
Evans, Jeff ;
Hall, Jacqueline A. ;
Kinrade, Sally ;
Jones, David ;
Jones, Paul S. ;
Jones, Rob ;
Marshall, John F. ;
Panico, Maria Beatrice ;
Shaw, Jacqui A. ;
Steeg, Patricia S. ;
Sullivan, Mark ;
Tong, Warwick ;
Westwell, Andrew D. ;
Ritchie, James W. A. ;
Berg, R. ;
Drysdale, M. ;
Eccles, S. ;
Elvin, P. ;
Harris, A. ;
Ireson, C. ;
Machesky, L. ;
McLeod, R. ;
Muschel, R. ;
Newell, H. ;
Pittman, M. ;
Roman, B. ;
Santos, C. ;
Sibson, N. ;
Smith, A. ;
Waddell, I .
NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (03) :185-204
[9]   Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica [J].
Antonio Hernandez-Luna, Marco ;
Luria-Perez, Rosendo .
JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
[10]   Probing the tumor micro(b)environment [J].
Atreya, Chloe E. ;
Turnbaugh, Peter J. .
SCIENCE, 2020, 368 (6494) :938-939